Vaccination against human papillomavirus - An impact on preterm delivery? Estimations based on literature review

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 3, 2009, Pages 255-260

  Sjøborg, Katrine Dønvold ^a   Eskild, Anne ^b,c,d  

^a Oestfold Hospital Trust   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cervical cone excision; Cervical intraepithelial neoplasia (CIN); Human papillomavirus (HPV); Preterm delivery; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADULT; CANCER IMMUNIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREGNANCY; PREMATURE BIRTH;

EID: 60849117535     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802699100     Document Type: Review

References (37)

1. Wright TC, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189:295-304.
2. Royal College of Obstetricians and Gynaecologists. Lower Genital Tract Neoplasia: study group recommendations 2003. Available from: URL: http://www.rcog.org.uk/mainpages.asp?PageID=1146 (accessed Feb 2006).
3. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000;CD001318.
4. Sjoborg KD, Vistad I, Myhr SS, Svenningsen R, Herzog C, Kloster-Jensen A, et al. Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand. 2007;86:423-8.
5. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol. 2003;102:1058-62.
6. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489-98.
7. Nohr B, Tabor A, Frederiksen K, Kjaer SK. Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstet Gynecol Scand. 2007;86:596-603.
8. Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2007;109:309-13.
9. Bruinsma F, Lumley J, Tan J, Quinn M. Precancerous changes in the cervix and risk of subsequent preterm birth. BJOG. 2007;114:70-80.
10. El-Bastawissi AY, Becker TM, Daling JR. Effect of cervical carcinoma in situ and its management on pregnancy outcome. Obstet Gynecol. 1999;93:207-12.
11. International Agency for Research on Cancer (IARC). Cervix cancer screening. Handbook of cancer prevention, Vol. 10. Lyon: IARC Press, 2005.
12. National Health Service. Cervical Screening Programme, England: 2004-2005. Leeds: Health and Social Care Information Service; 2005. Report No.: Statistical Bulletin 2005/09/HSCIC.
13. The Cancer Registry of Norway. Cancer in Norway 2005. Oslo, 2007.
14. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690-8.
15. Walboomers JM, Meijer CJ. Do HPV-negative cervical carcinomas exist? J Pathol. 1997;181:253-4.
16. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.
17. Koutsky LA, Harper DM. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine. 2006;24:114-21.
18. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-27.
19. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367:1247-55.
20. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369:2161-70.
21. Platt MJ, Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et al. Trends in cerebral palsy among infants of very low birthweight ( <1500 g) or born prematurely ( <32 weeks) in 16 European centres: a database study. Lancet. 2007;369:43-50.
22. Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol. 2004;104:78-87.
23. Yu VY. Global, regional and national perinatal and neonatal mortality. J Perinat Med. 2003;31:376-9.
24. Richardus JH Graafmans WC Verloove-Vanhorick SP Mackenbach JP EuroNatal International Audit Panel, EuroNatal Working Group. Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit. BJOG 2003;110:97-105.
25. Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360:1489-97.
26. The Pathology Data Bank of Denmark; 2007. Available at: http://www.patobank.dk/ (accessed Sep 2007).
27. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45:320-3.
28. Eurostat . European Commision. Study of low fertility in the regions of the European Union: places periods and causes. Populations and Social Conditions 3/2004/F/no 4.
29. Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, et al. HPV and cervical cancer in the world 2007 report. Vaccine. 2007;25:C1-230.
30. European Medicines Agency. Assessment report for Gardasil. European Medicines Agency. London. 2008. Available online at: http://www.emea.europa.eu/ humandocs/PDFs/EPAR/gardasil/EMEA-H-703-II-06-AR.pdf (accessed Jul 2008).
31. WHO vaccine-preventable disease: monitoring system. 2006 global summary. Available at: http://www.who.int/vaccinesdocuments/GlobalSummary/GlobalSummary (accessed Aug 2006).
32. Sysvak dekningsstatistikk. Available at: http://www.fhi.no/tema/vaksine/ dekning/ (accessed Nov 2007).
33. Lund E, Bjerkedal T. Cancer in situ of the uterine cervix. Increased perinatal death and prematurity after conization. J Nor Med Assoc. 1986;106:543-6.
34. Kristensen J, Langhoff-Roos J, Wittrup M, Bock JE. Cervical conization and preterm delivery/low birth weight. A systematic review of the literature. Acta Obstet Gynecol Scand. 1993;72:640-4.
35. World Health Organization . WHO Office of information. WHO Features 1990;152:1-6.
36. Simms I, Fairly C. Epidemiology of genital warts in England and Wales: 1971-1994. Genitourin Med. 1997;73:365-7.
37. Wallace LA, Young D, Brown A, Cameron JC, Ahmed S, Duff R, et al. Costs of running a universal adolescent hepatitis B vaccination programme. Vaccine. 2005;23:5624-1.